Cytosorbents ROA 2010-2023 | CTSO
Cytosorbents ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2023-12-31 | $-0.03B | $0.05B | -53.33% |
2023-09-30 | $-0.02B | $0.05B | -41.82% |
2023-06-30 | $-0.03B | $0.05B | -44.44% |
2023-03-31 | $-0.03B | $0.06B | -49.01% |
2022-12-31 | $-0.03B | $0.06B | -47.31% |
2022-09-30 | $-0.04B | $0.06B | -53.59% |
2022-06-30 | $-0.04B | $0.07B | -41.30% |
2022-03-31 | $-0.03B | $0.08B | -31.69% |
2021-12-31 | $-0.02B | $0.09B | -25.95% |
2021-09-30 | $-0.02B | $0.10B | -17.30% |
2021-06-30 | $-0.01B | $0.10B | -11.61% |
2021-03-31 | $-0.01B | $0.09B | -10.91% |
2020-12-31 | $-0.01B | $0.09B | -11.15% |
2020-09-30 | $-0.01B | $0.10B | -19.64% |
2020-06-30 | $-0.02B | $0.05B | -45.64% |
2020-03-31 | $-0.02B | $0.04B | -56.25% |
2019-12-31 | $-0.02B | $0.03B | -69.57% |
2019-09-30 | $-0.02B | $0.03B | -68.85% |
2019-06-30 | $-0.02B | $0.03B | -53.54% |
2019-03-31 | $-0.02B | $0.03B | -56.72% |
2018-12-31 | $-0.02B | $0.03B | -51.91% |
2018-09-30 | $-0.02B | $0.03B | -49.59% |
2018-06-30 | $-0.01B | $0.04B | -51.38% |
2018-03-31 | $-0.01B | $0.03B | -41.67% |
2017-12-31 | $-0.01B | $0.02B | -47.37% |
2017-09-30 | $-0.01B | $0.02B | -70.97% |
2017-06-30 | $-0.01B | $0.02B | -86.27% |
2017-03-31 | $-0.01B | $0.01B | -114.29% |
2016-12-31 | $-0.01B | $0.01B | -109.09% |
2016-09-30 | $-0.01B | $0.01B | -88.89% |
2016-06-30 | $-0.01B | $0.01B | -93.62% |
2016-03-31 | $-0.01B | $0.01B | -58.33% |
2015-12-31 | $-0.01B | $0.01B | -74.07% |
2015-09-30 | $-0.02B | $0.01B | -133.33% |
2015-06-30 | $-0.02B | $0.01B | -141.67% |
2015-03-31 | $-0.02B | $0.02B | -186.67% |
2014-12-31 | $-0.02B | $0.01B | -175.61% |
2014-09-30 | $-0.01B | $0.01B | -97.30% |
2014-06-30 | $-0.01B | $0.01B | -90.32% |
2014-03-31 | $-0.01B | $0.01B | -104.35% |
2013-12-31 | $-0.01B | $0.00B | -171.43% |
2013-09-30 | $-0.01B | $0.00B | -184.62% |
2013-06-30 | $-0.01B | $0.00B | -200.00% |
2013-03-31 | $-0.01B | $0.00B | -200.00% |
2012-12-31 | $-0.01B | $0.00B | -200.00% |
2012-09-30 | $-0.01B | $0.00B | -218.18% |
2012-06-30 | $-0.01B | $0.00B | -254.55% |
2012-03-31 | $-0.01B | $0.00B | -233.33% |
2011-12-31 | $-0.01B | $0.00B | -233.33% |
2011-09-30 | $-0.01B | $0.00B | -200.00% |
2011-06-30 | $-0.01B | $0.00B | -200.00% |
2011-03-31 | $-0.00B | $0.00B | -228.57% |
2010-12-31 | $-0.00B | $0.00B | -200.00% |
2010-09-30 | $-0.00B | $0.00B | -200.00% |
2010-06-30 | $-0.00B | $0.00B | -200.00% |
2010-03-31 | $-0.00B | $0.00B | -171.43% |
2009-12-31 | $-0.00B | $0.00B | -150.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.044B | $0.036B |
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
Stryker (SYK) | United States | $127.690B | 31.66 |
Boston Scientific (BSX) | United States | $107.347B | 34.19 |
Medtronic (MDT) | Ireland | $105.881B | 14.99 |
EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
ResMed (RMD) | United States | $32.074B | 30.08 |
Terumo (TRUMY) | Japan | $24.746B | 34.95 |
Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
Baxter (BAX) | United States | $20.379B | 14.86 |
Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
Insulet (PODD) | United States | $11.637B | 61.10 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.869B | 23.44 |
BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
Haemonetics (HAE) | United States | $4.621B | 23.63 |
Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
Envista Holdings (NVST) | United States | $3.504B | 13.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
Neogen (NEOG) | United States | $2.630B | 25.29 |
Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
ICU Medical (ICUI) | United States | $2.311B | 17.24 |
TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
Owens & Minor (OMI) | United States | $1.922B | 18.45 |
Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
InMode (INMD) | Israel | $1.439B | 7.45 |
National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
Warby Parker (WRBY) | United States | $1.271B | 0.00 |
AtriCure (ATRC) | United States | $1.121B | 0.00 |
MacroGenics (MGNX) | United States | $0.911B | 0.00 |
Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
Evolus (EOLS) | United States | $0.662B | 0.00 |
Jin Medical (ZJYL) | China | $0.626B | 0.00 |
Quanterix (QTRX) | United States | $0.595B | 0.00 |
Valneva SE (VALN) | France | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
PetIQ (PETQ) | United States | $0.486B | 18.16 |
TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
ZimVie (ZIMV) | United States | $0.431B | 26.37 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
Zynex (ZYXI) | United States | $0.361B | 41.52 |
Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
Cerus (CERS) | United States | $0.310B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
InterCure (INCR) | Israel | $0.121B | 20.46 |
Fonar (FONR) | United States | $0.103B | 8.84 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Chimerix (CMRX) | United States | $0.080B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.77 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |